Nirsevimab
ATC J06BD08 · 11 markets · 20 records
AU 3 records · 3 strengths
- 100 mginjectionBEYFORTUS nirsevimab 50mg in 0.5mL solution for injection prefilled syringe
- 50 mginjectionBEYFORTUS nirsevimab 50mg in 0.5mL solution for injection prefilled syringe
Records without a stated strength · 1 BEYFORTUS
US 2 records · 1 strengths
- 100 mginjectionBEYFORTUS
GB 2 records · 2 strengths
- 100 mg/1 mLinjectionBeyfortus 50mg/0.5ml solution for injection pre-filled syringes
- 50 mg/0.5 mLinjectionBeyfortus 50mg/0.5ml solution for injection pre-filled syringes
CA 2 records · 2 strengths
SG 2 records · 2 strengths
- 100 mg/1 mLinjectionBEYFORTUS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 50 MG/ 0.5 ML
- 50 mg/0.5 mLinjectionBEYFORTUS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 50 MG/ 0.5 ML
CN 2 records · 2 strengths
ES 2 records · 2 strengths
- 100 mginjectionBEYFORTUS PRECARGADA
- 50 mginjectionBEYFORTUS PRECARGADA
HK 2 records · 1 strengths
Records without a stated strength · 1 BEYFORTUS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 50 MG/ 0.5 ML
MX 1 records · 1 strengths
Records without a stated strength · 1 BEYFORTUS
TW 1 records · 1 strengths
Records without a stated strength · 1 Beyfortus 100 mg/mL solution for injection、樂唯初注射劑100毫克/毫升
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 BEYFORTUS
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100 mg injection | BEYFORTUS | BEYFORTUS nirsevimab 50mg in 0.5mL solution for injection prefilled syringe | 乐唯初尼塞韦单抗 | BEYFORTUS PRECARGADA | |||||||
| 50 mg injection | BEYFORTUS nirsevimab 50mg in 0.5mL solution for injection prefilled syringe | 乐唯初尼塞韦单抗 | BEYFORTUS PRECARGADA | ||||||||
| 100 mg/1 mL injection | Beyfortus 50mg/0.5ml solution for injection pre-filled syringes | BEYFORTUS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 50 MG/ 0.5 ML | |||||||||
| 50 mg/0.5 mL injection | Beyfortus 50mg/0.5ml solution for injection pre-filled syringes | BEYFORTUS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 50 MG/ 0.5 ML | |||||||||
| 100 mg liquid | BEYFORTUS | ||||||||||
| 50 mg liquid | BEYFORTUS | ||||||||||
unknown | BEYFORTUS | BEYFORTUS SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 50 MG/ 0.5 ML | BEYFORTUS | ||||||||
injection | Beyfortus 100 mg/mL solution for 樂唯初注射劑100毫克/毫升 | ||||||||||
liquid | BEYFORTUS |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
4 more strength/form rows are recorded only in GB · SG · MX · TW and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en GB · SG · MX · TW que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 GB · SG · MX · TW 有记录(未在本表显示)。 另有 4 個規格/劑型僅在 GB · SG · MX · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.